Grifols is a Spanish biotech company that specializes in the production of plasma-derived medicines, diagnostic systems, and medical devices. The company was founded in 1940 and has since grown to become a global leader in the biotech sector. With a presence in over 100 countries, Grifols is committed to providing innovative solutions that improve the health and well-being of people around the world.

As a biotech company, Grifols recognizes the importance of sustainability and environmental responsibility. The company has made significant efforts to reduce its carbon footprint and promote decarbonisation. Grifols has set ambitious goals to reduce its greenhouse gas emissions by 30% by 2030 and achieve carbon neutrality by 2040. To achieve these goals, the company has implemented a range of initiatives, including the use of renewable energy, energy efficiency measures, and the adoption of low-emission technologies.

One of the key ways that Grifols is promoting decarbonisation is through the use of renewable energy. The company has made significant investments in renewable energy sources such as solar and wind power. Grifols has installed solar panels on the roofs of its facilities, which generate clean energy and reduce the company's reliance on fossil fuels. In addition, Grifols has signed corporate power purchase agreements (PPAs) with renewable energy providers, which enable the company to purchase renewable energy at a fixed price over a long-term period.

Corporate PPAs are an important tool for companies like Grifols that are committed to reducing their carbon footprint. By entering into a PPA, Grifols is able to support the development of new renewable energy projects and contribute to the growth of the renewable energy sector. In addition, corporate PPAs provide Grifols with a reliable and cost-effective source of renewable energy, which helps the company to achieve its sustainability goals.

Grifols is also committed to improving its corporate energy efficiency. The company has implemented a range of measures to reduce its energy consumption and improve its energy efficiency. For example, Grifols has installed energy-efficient lighting systems, implemented building automation systems, and optimized its production processes to reduce energy consumption. These measures have not only helped Grifols to reduce its carbon footprint but have also resulted in significant cost savings for the company.

In addition to its efforts to promote decarbonisation and improve its corporate energy efficiency, Grifols is also committed to reducing its environmental impact in other areas. The company has implemented a range of initiatives to reduce waste, conserve water, and promote sustainable sourcing. For example, Grifols has implemented a waste reduction program that aims to reduce the amount of waste generated by the company and increase the amount of waste that is recycled or reused. The company has also implemented water conservation measures, such as the use of water-efficient technologies and the reuse of water in its production processes.

Overall, Grifols is a company that is committed to sustainability and environmental responsibility. The company recognizes the importance of decarbonisation and is taking significant steps to reduce its carbon footprint and promote the use of renewable energy. Through its use of corporate PPAs, energy efficiency measures, and renewable energy sources, Grifols is demonstrating its commitment to a sustainable future. As a global leader in the biotech sector, Grifols is setting an example for other companies to follow and is helping to drive the transition to a low-carbon economy.